Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Copy That, '43! Appreciate the solid feedback!
GLTA!!!
Ok, so what's new!? The following is why there should be changes at the top:
"NHS, Boots, Lloyds, on 4/1/2018 the NHS published ActiPatch in their Drug Tariff, making it available for insurance coverage. Shortly thereafter BIEL pulled ActiPatch from the UK OTC shelves as prescriptions were needed for NHS coverage. BIEL subsequently found that there was another Local Layer of the NHS Bureaucracy that controlled what doctors can prescribe. These Community NHS Groups need to approve the use of medicines and devices before they can be prescribed in their areas."
BIEL has been around for more than 10 years, so to be blind sided by something like this is inexcusable. Come on folks, at this juncture of BIEL's existence, there is no excuse for this degree of incompetence.
GLTA!!!
P.S., A product doesn't have to be hidden behind the counter in order for a doctor to cite it for patient's use. Thus, make it advantageous for doctors to encourage patients to use ACTIPATCH (Oh! I don't know, can we say kickback ). Nonetheless, doctors and the public can be educated about a product simultaneously, by whatever method(s) chosen by the purveyor ("Elementary Mr. Watson!"). Again, IMHO, this is another instance of trying to get something done on the cheap, orchestrate of course, by BIEL's leadership! Enough Is Enough!!
Your Quote: "There is plenty of fruit to drop, the tree has been shaken. We will see in a couple of days. "
Hmmm! Just what does that mean, '43? With all do respect, can we be a little more direct in our statements? Appreciate cha!
GLTA!!!
Well, yes, Gramps, it is interesting to see those types of comments. Not Good! But some may posit, it is more interesting to witness a company struggling to sale its product which, by all accounts, relieves pain in a measurable and effecting way. The pain phenomenon is a bane on human quality of life all over the would. This crippling health nemesis is taking its pound of flesh each and every day, and this product is not being sold any where near market expectations. What?! For Real! How Come?! Something is definitely wrong here!
But Oh Well...!
GLTA!!!
Why is this company still in existence? That's the most relevant question!
DB's position is quite reasonable, especially when considering what transpired during the last couple of months regarding BIEL. It has been an unmitigated disaster! So don't attack the messenger, please! Stay strong DB!
GLTA!!!
P.S., "I am in earnest - I will not equivocate - I will not excuse - I will not retreat a single inch - and I will be heard!"
- William Lloyd Garrison -
How do you know a PR is coming in a few days? If it's just conjecture on your part, then please make that clear. But if it's from a reliable source (confidential I'm sure), then make that clear as well. It doesn't help, at all, to make statements on this board which will mislead. Furthermore, if BIEL would just leverage advertising, presuming they don't have ready cash on hand to do so, most of their problems would be solved. Yours truly just doesn't accept blatant incompetence for the actions of the CEO. His actions are motivated by something, but what, IMHO!!?
GLTA!!!
P.S. If BIEL would, or could borrow a million or so dollars and produce and air ADS during the Super Bowl, they would recover their cost overnight, and make a profit to boot. I have no doubts!!
"It's elementary Mr. Watson!"
With the right leadership and correct politics, this company would have been off and running years ago. I'm pretty sure about that! Furthermore, maybe us investors should search for a silver lining in this troubling situation. Thus, from my vantage point, BIEL's inability to gain traction within the marketplace it seeks, have given us investors a rare opportunity to get in on the ground floor of a gem in the making. IMHO, that is the potential saving grace for us investors, in particular, relatively late comers to the party, so to speak.
GLTA!!!
Those are pitiful numbers! Wow!!
With all do respect, all this back-and-forth conjecture on this board about BIEL's failures and machinations is quite entertaining, sometimes. But IMHO, it would be more constructive, at the moment, to concentrating on what we can possibly do to put pressure on BIEL to, at least, inform us on what their way forward plans are. But then again, maybe we are not in any position to do anything regarding that issue. But it's a thought!!
GLTA!!!
As shareholders, are we totally feckless when it comes to influencing this company to go in another direction, regarding its management philosophy? I'm not an expert, by far, when it involves shareholder powers vis-à-vis company operational sovereignty, but we owe it to ourselves to explore options regarding that area. It seems pretty certain that time is running out on whether this company has an extended future if management does not change its management model. IMHO!!
GLTA!!!
Well, I think it's pretty clear. Do you think you and other shareholders should be saddled with the primary responsibility to promote and generate public awareness of BIEL's products? If you think that's your answerability, then have at it.
GLTA!!!
Hey! Watch out!!!! There's a big ole blue elephant in the room. Thus, why BIEL doesn't make a serious effort to generate awareness for its own product(s)? That's the question! The shareholder shouldn't be burdened with that responsibility. Something is definitely screwy with this company. But what is the nature of the skullduggery that's going on behind the curtains? Hmmm!
GLTA!!!
What Run?
I hope BIEL succeeds, of course, but making open ended statements like those in the CEO's letter in response to the stock downturn, are not very helpful, IMO.
GLTA!!!
Where is the timeline on any of these open ended pronouncements? This is all loose pablum, IMO! Ridiculous!!
GLTA!!!
Yes, it's quite sad! Just think about it, as the saying goes! All that hype language, and we got nothing! Absolutely Nothing! Now that kind of parlance is starting up again on this board. It's pretty shameful behavior, for sure!
GLTA!!!
Why won't BIEL market HealFast? They won't market anything! This is business malfeasance at its most virulence! It seem if they don't want to make money! This makes no sense! My Goodness!!
GLTA!!!
There is no guarantee that BIEL will be around a year and a half from now, if management continue their errant ways?
GLTA!!!
Ya! Just what is the latest on the Allay trial? Actually, I thought that was completed months ago. Let's be honest with ourselves, thus, no one is as incompetent as BIEL's brain trust, unless it's on purpose. Those BIEL people are playing games, no doubt. Oh, ya! Another thing, does anyone know the status of the 510(k) resubmit for Back (i.e., for the ladies)?
GLTA!!!
So that's BIEL's CEO?
About a week, or so ago, I sent an email to Mr. Knopick, as well. I requested info pertaining to the resubmission of the "Back" 510(K), and got essentially nothing! Actually, the guy gave short shrift to my inquiry. Actually he was a little curt! Oh Well, BIEL's display of unprofessionalism will never disappoint!!
GLTA!!!
P.S. It appears that these folks are not ready for "Prime-Time", from top to bottom! Really Unfortunate!!
'65, Appreciate the great feedback!
GLTA!!!
"BIG BIG lawsuits coming down the pike!!!! GO BIEL$$$$$$$$$$" That's a interesting, declarative statement. please expound on your premise!
GLTA!!!
'65, Thanks for the info! That bit of update info regarding BIEL's current activities served to Allay some of my anxieties that I was experiencing. Those anxieties were spurred on by my ponder, in regards to what would be BIEL's next step. Ya know, if BIEL would just keep us posted on what's going on with company activities, that would go a long way to Allay a lot of shareholder apprehension. One other thing '65, the Sree statement about completing the new Women’s 501k, "in a timely manner", is lacking in definite boundaries. So '65, I wonder if it would be possible to contact Sree again, and request a more precise timeframe regarding the completion? Again, Thanks '65!
GLTA!!!
Agreed! To witness all that potential withering on the vine, one just might be motivated to think this fecklessness is intentional. But actually, I proffer the previous point as a trope, just to emphasize the absurdness in regards to how this company is being run. So to be reasonable and fair, what would AW and his clueless staff have to gain by sabotaging the company?
GLTA!!!
Well, don't count on the CEO going anywhere, for he is dug in like an Alabama tick. A hostile takeover would be the next plausible gambit, which would have a high probability to succeed.
GLTA!!!
Hey! All, what about Allay! The trials are done, so what's the wait regarding a 510(k) submission? Come on BIEL, half the world's population will be very grateful. But you gotta advertise the d*me thing though, if you want to make money!
GLTA!!!
I agree! But it seems as though BIEL is disregarding practically half the world's population as a customer. The previous statement is an abstract premise, but I think the point is made.
Furthermore, no CEO and his management team could be this incompetent, or, could they? Incredible!!
GLTA!!!
Well, what about Allay, that product could possibly be a winner big time for BIEL. Wonder why BIEL isn't push that potential gold mine?
GLTA!!!
I agree! It just makes no sense, thus, how BIEL is handling its business operations. They commit misstep after misstep! Why can't they learn from their past mistakes? I'm just flummoxed by the whole thing!
GLTA!!!
P.S. With all do respect, maybe the CEO should consider, at most, an emeritus relationship with the company, at this point. IMHO!!
Well, BIEL still may have a consolation opportunity, after that monumental failure at the hands of the FDA. The opportunity of which I'm referring is the resubmission of a 510(k), with a women's bias. Apparently, the clinical trial metrics were gender bifurcated, which gave the FDA the opening to deny in the first place. So, why can't BIEL use the women's prong of that clinical trial data for an expedient 510(k) resubmission? Thus, such an exercise shouldn't take an exorbitant amount of time. They should be able to do that within a few months, are so. Also, what about the Allay product, the trials for it is complete, correct? So, what if BIEL submitted a 510(k) for it early next year? Thus, the results of that submission should be available before the summer of next year. Now, I'm not saying put all your Actipatch eggs in that "All Important" FDA clearance basket, BIEL. You should be able to chew gum, and skip at the same time. Yes, work on your sales and branding responsibilities, as a primary focus. But also dedicate a cadre of BIEL technical folks to concentrate on securing FDA clearances, as a plenum group, if you will. I can imagine this happening all within one calendar year, why not? Hey! Maybe I'm missing something, and maybe I'm all wet on this, but it's a plan, right? All as MHO, of course!!
GLTA!!!
Well, BIEL still may have a consolation opportunity, after that monumental failure at the hands of the FDA. The opportunity of which I'm referring is the resubmission of a 510(k), with a women's bias. Apparently, the poor clinical trial metrics were gender bifurcated, which gave the FDA the opening to deny in the first place. So, why can't BIEL use the women's prong of that clinical trial data for an expedient 510(k) resubmission? Thus, such an exercise shouldn't take two years. They should be able to do that within a few months, are so. Also, what about the Allay product, the trials for it is complete, correct? So, what if BIEL submitted a 510(k) for it early next year? Thus, the results of that submission should be available before the summer of next year. Now, I'm not saying put all your Actipatch eggs in that "All Important" FDA clearance basket, BIEL. You should be able to chew gum, and skip at the same time. Yes, work on your sales and branding responsibilities, as a primary focus. But also dedicate a cadre of BIEL technical folks to concentrate on securing FDA clearances, as a plenum group, if you will. I can imagine this happening all within one calendar year, why not? Hey! Maybe I'm missing something, and maybe I'm all wet on this, but it's a plan, right? All as MHO, of course!!
GLTA!!!
No, not being snarky! I'm being quite direct and serious!
Well, may be! You know, a RS is a very tricky proposition. I won't go into the various scenarios, but BIEL needs to get other fundamental, organizational structures fixed before a RS should be considered. IMHO!!
GLTA!!!
Here! Here! '101! The FDA even created a unique category for the Actipatch. The CEO couldn't even parlay that gimme into a successful outcome. How Sad Is That?! My Heavens!!
GLTA!!!
P.S. Another thing, who would submit unnecessary poor trial data to the FDA when trying to secure clearance? Again, who would do that?! Wow!!
The BIEL Manifesto:
Google, Microsoft, Amazon, somebody, anybody of appropriate means, if you are listening, or reading, or whatever, Please buy BIEL!! Yes! Buy it, promote it, advertise BIEL product(s) and, thus, bring the company up to a level of viability and potential it truly deserves!! Viva BIEL, Comrades!!
GLTA!!!
According to BIEL, the immediate submission of a new 510(k) is forthcoming. Awaiting to hear just when BIEL!! Well, à la Bill Clinton... It depends upon what the meaning of the word 'immediate' is.
GLTA!!!
With all those positives and advantages, the question is frequently asked... so, why BIEL can't make a serious go of it? I'm a BIEL Long, and not here to be a opportune critic. But my goodness, it would seem one would have to intentionally try very hard indeed, to fail with a product such as Actipatch in your back pocket. Extraordinary!!
GLTA!!!
The information below is provide by a well respected Company Operation Analysis Platform.
BIEL Analysis:
* Compared with its chosen peers, the company's annual revenues and earnings change at a slower rate, implying a lack of strategic focus and/or lack of execution success.
* BIEL-US's return on assets currently and over the past five years has trailed the peer median and suggests the company might be operationally challenged relative to its peers.
* BIEL-US's operating performance may not allow it to raise additional debt.
Wow!! In this case Leadership is not a MacGuffin!
GLTA!!!